علاج SIADH في نقص صوديوم الدم المزمن دون أعراض حادة وبحالة حجم طبيعية

References

DOI: 10.1530/EJE-13-1020

For demeclocycline and lithium, there is some evidence of possible harm, so we advise against their use for management of any degree of chronic hyponatraemia in patients with SIAD.

In moderate or profound hyponatraemia, we suggest the following can be considered equal second-line treatments: increasing solute intake with 0.25–0.50 g/kg per day of urea or a combination of low-dose loop diuretics and oral sodium chloride (2D).